Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Noradrenaline synthesis is a multi-step enzymatic pathway responsible for the conversion of the amino acid tyrosine into norepinephrine (noradrenaline), an important neurotransmitter and hormone. The pathway begins with phenylalanine being hydroxylated to tyrosine, followed by successive enzymatic steps: tyrosine is converted to L-DOPA by tyrosine hydroxylase (the rate-limiting step), L-DOPA is decarboxylated to dopamine by DOPA decarboxylase, and dopamine is then converted to norepinephrine by dopamine β-hydroxylase within vesicles in noradrenergic neurons or chromaffin cells. In some cells, norepinephrine may be further methylated into epinephrine. Regulation and inhibition of this pathway impact levels of neurotransmitters central to multiple neurological and cardiovascular functions and diseases.
Drugs inhibit or modulate specific enzymes such as tyrosine hydroxylase, DOPA decarboxylase, or dopamine β-hydroxylase
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Noradrenaline synthesis.